AEON Biopharma AEON
NYSE AEON
$0.24 +0.01 (+4.75%)
As of: Oct 21, 2026 · 3:52 PM EDT

AEON Biopharma (AEON) Preferred Stock Liabilities (2021 - 2023)

Updated

AEON Biopharma's Preferred Stock Liabilities was $21.19 million in Q2 2024, up 1.0% from the prior quarter.

Analysis

AEON Biopharma (AEON) Preferred Stock Liabilities (2021 - 2023) Analysis & Trends

At the end of FY2022, Preferred Stock Liabilities at AEON Biopharma came in at $278.49 million, up 0.9% from FY2021.

  • In earlier years, Preferred Stock Liabilities was $276 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 AEON Biopharma 12.25 Mn -8.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 21.19 Mn
Mar 31, 2023 20.99 Mn
Dec 31, 2022 278.49 Mn
Sep 30, 2022 276.90 Mn
Jun 30, 2022 276.08 Mn
Mar 31, 2022 276.00 Mn
Dec 31, 2021 276.00 Mn
Sep 30, 2021 276.00 Mn
Jun 30, 2021 276.00 Mn
Mar 31, 2021 276.00 Mn
API Access

AEON Biopharma Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=AEON&period=max&api_key=YOUR_API_KEY